Salesforce (CRM) is set to report fiscal third-quarter results tomorrow after the close of trading, and Wedbush Securities is ...

Key Takeaways Wedbush upgraded Snowflake as the analysts predicted that the artificial intelligence software era is ...

Some panned the billionaire for overspending on Twitter, but the platform is winning him favor with Donald Trump and ...

Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) is one of the best stocks to buy for long term growth. The ...

The $7 billion RIA welcomes a seasoned professional to help scale the business and draw talent across its private-client and ...

Investing.com -- Wedbush analysts expect tech stocks to end the year on a positive note with a “Santa rally,” citing positive catalysts including deregulation under Donald Trump’s second term and ...

Major technology stocks are positioned for a strong year-end rally as artificial intelligence initiatives accelerate and ...

Wedbush upgraded Voyager Therapeutics (VYGR) to Outperform from Neutral with a price target of $11, up from $7, after ...

Tesla’s strategic pivot toward AI and autonomy reinforces its position as a leading disruptive technology company, not merely an automaker, the analysts said. Investors are closely watching regulatory ...

Tavares' sudden departure caps a series of problems this year for the automaker, especially in the United States.

Wedbush has assumed coverage of Voyager Therapeutics (NASDAQ:VYGR) with an outperform rating, highlighting the company’s TRACER platform. The investment firm said it believes TRACER alone should ...